Management ChangeJun 12, 2026, 04:12 PM
Aardvark Therapeutics Retains CFO/COO Sun & CMO Jaiman with Bonuses
AI Summary
Aardvark Therapeutics, Inc. has entered into retention bonus agreements with its Chief Financial Officer and Chief Operating Officer, Nelson Sun, and its Chief Medical Officer, Manasi Jaiman. Mr. Sun will receive a total cash retention bonus of $346,500, while Dr. Jaiman will receive $357,000. Both bonuses are contingent on their continued employment through January 1, 2027, or earlier termination without cause or resignation for good reason.
Key Highlights
- Aardvark Therapeutics entered a retention bonus agreement with CFO and COO Nelson Sun.
- Nelson Sun will receive a cash retention bonus of $346,500.
- Sun's bonus includes a $198,000 guaranteed annual bonus for 2026 and a $148,500 retention bonus.
- Bonus is payable January 1, 2027, contingent on continued employment.
- CMO Manasi Jaiman, M.D., M.P.H., also entered a retention bonus agreement.
- Dr. Jaiman will receive a cash retention bonus of $357,000.
- Jaiman's bonus includes a $204,000 guaranteed annual bonus for 2026 and a $153,000 retention bonus.
- Jaiman's bonus is also payable January 1, 2027, contingent on continued employment.
Price Impact
More from AARD